| BCN | basal cell nevus; bilateral cortical necrosis |
|---|---|
| BCNS | basal cell nevus syndrome |
| BCNU | 1,3-bis-(2-chloroethyl)-1-nitro-sourea; bleomycin and camustine |
| BCNS | Basal Cell Nevus Syndrome |
|---|---|
| BCNU | bis-chlorethyl nitrosourea |
| BCNU | <chemical> A cell-cycle phase non-specific alkylating antineoplastic agent. It is used in the treatment of brain tumours and various other malignant neoplasms. This substance may reasonably be anticipated to be a carcinogen according to the fourth annual report on carcinogens (ntp 85-002, 1985). Pharmacological action: antineoplastic agent, alkylating, carcinogens. Chemical name: Urea, N,N'-bis(2-chloroethyl)-N-nitroso- (12 Dec 1998) |
|---|
| BCNU |
carmustine.
Ãâó: www.mercksource.com/pp/us/cns/cns_health_library.j...
|
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|